购物车
全部删除
您的购物车当前为空
MAGL-IN-22 (Compound 40) 是一种可逆、竞争性且选择性穿透血脑屏障的MAGL抑制剂,其对 hMAGL 的IC50为 0.34 μM。MAGL-IN-22 展现出显著的抗氧化和抗炎活性,能够激活Nrf2通路,同时显著抑制NFκB介导的炎症,并且不会引发细胞毒性。该化合物适用于神经退行性疾病、慢性疼痛和癌症的研究。

MAGL-IN-22 (Compound 40) 是一种可逆、竞争性且选择性穿透血脑屏障的MAGL抑制剂,其对 hMAGL 的IC50为 0.34 μM。MAGL-IN-22 展现出显著的抗氧化和抗炎活性,能够激活Nrf2通路,同时显著抑制NFκB介导的炎症,并且不会引发细胞毒性。该化合物适用于神经退行性疾病、慢性疼痛和癌症的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
MAGL-IN-22 相关产品
| 产品描述 | MAGL-IN-22 (Compound 40) is a reversible, competitive, and selective inhibitor of MAGL that is capable of crossing the blood-brain barrier, with an IC50 of 0.34 μM for hMAGL. It exhibits significant antioxidant and anti-inflammatory properties, activating the Nrf2 pathway and markedly suppressing NFκB-mediated inflammation, without inducing cytotoxic effects. MAGL-IN-22 is applicable in research on neurodegenerative diseases, chronic pain, and cancer. |
| 分子量 | 365.40 |
| 分子式 | C22H20FNO3 |
| CAS No. | 2720674-71-3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容